Analysts delivered a mixed verdict on US financials this week. The moves reveal a growing divide between Wall Street giants and regional lenders.
Goldman Sachs got the headline call. Evercore ISI analyst Glenn Schorr raised his target price to $1,075 from $950. That is a $125 jump on a stock with a $313 billion market cap. Schorr kept his Buy rating intact. The implied upside from current consensus pricing is substantial.
Regional banks told a different story. Huntington Bancshares was downgraded by consensus analysts. Truist Financial also fell a notch on the consensus ladder. Both stocks had their hold counts trimmed as sell ratings edged up.
On the positive side, American Express, M&T Bank, KeyCorp, and Citizens Financial Group all saw target price increases. Citizens got a double boost. Evercore's John Pancari lifted his individual target to $80 from $75. The broader consensus average also ticked higher.
Evercore ISI drove much of today's activity. The firm touched at least five names across healthcare, storage, and banking. Edwards Lifesciences earned an upgrade to $100. Danaher slipped to $230 from $232.
The pattern is clear. Large-cap financials are gaining favour. Smaller regionals face more pressure.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
